What is Betamethasone - Behvazan 001%?
Betamethasone - Behvazan 001% topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. Betamethasone - Behvazan 001% is a corticosteroid (cortisone-like medicine or steroid).
Betamethasone - Behvazan 001% is available only with your doctor's prescription.
Betamethasone - Behvazan 001% indications
Betamethasone - Behvazan 001% gel (augmented) is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Treatment beyond two consecutive weeks is not recommended, and the total dose should not exceed 50 g per week because of potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
This product is not recommended for use in pediatric patients under 12 years of age.
How should I use Betamethasone - Behvazan 001%?
Use Betamethasone - Behvazan 001% lotion as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Shake well before each use.
- Place nozzle of the bottle very close to the affected area and gently squeeze a small amount of medicine onto the affected area. Do not touch the nozzle to the skin. Gently rub the medicine in until it is evenly distributed. Wash your hands after applying Betamethasone - Behvazan 001% lotion, unless your hands are part of the treated area. Do not apply Betamethasone - Behvazan 001% lotion to the face, groin, or armpit unless otherwise directed by your doctor.
- Do not cover the treating area with bandages, wrappings, or other dressings unless advised to do so by your health care provider.
- If you miss a dose of Betamethasone - Behvazan 001% lotion, apply it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.
Ask your health care provider any questions you may have about how to use Betamethasone - Behvazan 001% lotion.
Uses of Betamethasone - Behvazan 001% in details
Betamethasone - Behvazan 001% is used to treat allergic disorders, skin conditions, ulcerative colitis, arthritis, lupus, psoriasis, and bronchial asthma
Topical preparations of Betamethasone - Behvazan 001% are used to treat skin problems like eczema (a type of itchy skin rash), atopic dermatitis (inflammation of skin) and psoriasis of the scalp, hands and feet.
Betamethasone - Behvazan 001% description
Each gram of Betamethasone - Behvazan 001% (Betamethasone - Behvazan 001%*) Cream* contains: 640 mcg Betamethasone - Behvazan 001% (equivalent to 500 mcg Betamethasone - Behvazan 001%).
Each gram of Betamethasone - Behvazan 001% (Betamethasone - Behvazan 001%*) Ointment* contains: 640 mcg Betamethasone - Behvazan 001% (equivalent to 500 mcg Betamethasone - Behvazan 001%).
Betamethasone - Behvazan 001% (Betamethasone - Behvazan 001%*) Cream and Ointment contain Betamethasone - Behvazan 001%, a synthetic corticosteroid with anti-inflammatory activity to be administered topically.
Betamethasone - Behvazan 001% is a white to creamy white odorless crystalline powder insoluble in water; freely soluble in acetone and in chloroform; sparingly soluble in alcohol. It has a molecular weight of 504.16 and the empirical formula C28H37FO7; a chemical name of 9-fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione,17,21-dipropionate.
Betamethasone - Behvazan 001% dosage
Apply a thin film of Betamethasone - Behvazan 001% cream, 0.5% (augmented) to the affected skin areas once or twice daily. Therapy should be discontinued when control is achieved. Betamethasone - Behvazan 001% cream, 0.5% (augmented)is a high-potency corticosteroid. Treatment with Betamethasone - Behvazan 001% cream, 0.5% (augmented)should not exceed 50 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
Betamethasone - Behvazan 001% cream, 0.5% (augmented)should not be used with occlusive dressings unless directed by a physician.
Betamethasone - Behvazan 001% cream, 0.5% (augmented)is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae, or if skin atrophy is present at the treatment site.
Betamethasone - Behvazan 001% interactions
See also:
What other drugs will affect Betamethasone - Behvazan 001%?
There are no known drug interactions with topical Betamethasone - Behvazan 001%.
Betamethasone - Behvazan 001% side effects
See also:
What are the possible side effects of Betamethasone - Behvazan 001%?
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
In controlled clinical trials, involving 242 adult subjects, the adverse reaction associated with the use of Betamethasone - Behvazan 001% cream, 0.5% (augmented)reported at a frequency of 0.4% was stinging. It occurred in 1 subject.
In a controlled clinical trial involving 67 pediatric subjects from 3 months to 12 years of age, the adverse reactions associated with the use of Betamethasone - Behvazan 001% cream, 0.5% (augmented)occurred in 7 of 67 (10%) subjects. Reported reactions included signs of skin atrophy (telangiectasia, bruising, shininess).
Postmarketing Experience
Because adverse reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Postmarketing reports for local adverse reactions to topical corticosteroids may also include: burning, itching, irritation, dryness, folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, hypertrichosis, skin atrophy, striae, and miliaria.
Hypersensitivity reactions, consisting of predominantly skin signs and symptoms, e.g., contact dermatitis, pruritus, bullous dermatitis, and erythematous rash have been reported.
Betamethasone - Behvazan 001% contraindications
See also:
What is the most important information I should know about Betamethasone - Behvazan 001%?
Betamethasone - Behvazan 001% cream, 0.5% (augmented)is contraindicated in patients who are hypersensitive to Betamethasone - Behvazan 001%, to other corticosteroids, or to any ingredient in this preparation.
Active ingredient matches for Betamethasone - Behvazan 001%:
List of Betamethasone - Behvazan 001% substitutes (brand and generic names) | Sort by popularity |
Unit description / dosage (Manufacturer) | Price, USD |
Betamethasone-sobhan® 0.1% 15g Oint | |
Betapionate 0.05% | |
C.G.B. (Taiwan) | |
C.G.B. 10 g | |
Caditrigel (Vietnam) | |
Caditrigel 1 tube x 10 g | |
Demacot (Vietnam) | |
Demacot 1 tube 10 g | |
Dermal SA (Vietnam) | |
Dermal SA 1 tube 15 g | |
Dipoderm 0.05% | |
Diproderma (Singapore) | |
Diproderma Cream (Universal Twin Labs) | $ 0.41 |
Diprosone 0.064% | |
Diprosone 帝 (Hongkong) | |
Diprosone-OV (Indonesia) | |
Diprosone-OV 0.05 % x 5 g x 1's (Schering-plough) | $ 3.99 |
Diprosone-OV 0.05 % x 10 g x 1's (Schering-plough) | $ 6.42 |
DIPROVATE-ES (India) | |
20g | $ 1.08 |
Dovobet (Belgium, Canada, Greece, Ireland, Italy, Luxembourg, Netherlands, South Africa, United Kingdom) | |
Ointment; Topical; Betamethasone Dipropionate 0.5 mg; Calcipotriol 50 mcg / g (Formenti) | |
DR.PI.A.F (Taiwan) | |
DR.PI.A.F 1 g | |
DR.PI.A.F 5 g | |
DR.PI.A.F 10 g | |
DR.PI.A.F 16 g | |
DR.PI.A.F 20 g | |
DR.PI.A.F 100 g | |
Forever (Taiwan) | |
Forever 1 g | |
Gentizone (Vietnam) | |
Gentizone 1 tube 10 g | |
Hayamethasone 0.05% | |
LUPIDERM-M (India) | |
10g (Lupin) | $ 0.23 |
Lupiderm-M Betamethasone dipropionate0.05 % w/w, Miconazole nitrate2 % w/w. T-SOLN / 10g (Lupin) | $ 0.23 |
LUPIDERM-M cream 10g (Lupin) | $ 0.23 |
Lupiderm-M Betamethasone dipropionate0.05 % w/w, Miconazole nitrate2 % w/w. T-SOLN / 10g (Lupin) | $ 0.23 |
Occlucort | |
Philgenta (Vietnam) | |
Philgenta 1 tube 10 g | |
QUADRIMIX (India) | |
15g (Ind-Swift Limited) | $ 0.59 |
5g (Ind-Swift Limited) | $ 0.28 |
Quadrimix Betamethasone dipropionate0.05 % w/w, gentamicinsulphate 0.1 % w/w, tolnaftate1 % w/w, iodochlorhydroxyquinoline 1 %w/w, chlorocresol 0.1 % w/w. CRM / 15g (Ind-Swift Limited) | $ 0.59 |
Quadrimix Betamethasone dipropionate0.05 % w/w, gentamicinsulphate 0.1 % w/w, tolnaftate1 % w/w, iodochlorhydroxyquinoline 1 %w/w, chlorocresol 0.1 % w/w. CRM / 5g (Ind-Swift Limited) | $ 0.28 |
Quadrimix Skin 15 gm Cream (Ind-Swift Limited) | $ 0.59 |
Quadrimix Skin 5 gm Cream (Ind-Swift Limited) | $ 0.28 |
QUADRIMIX cream 15g (Ind-Swift Limited) | $ 0.59 |
QUADRIMIX cream 5g (Ind-Swift Limited) | $ 0.28 |
Quadrimix Betamethasone dipropionate0.05 % w/w, gentamicinsulphate 0.1 % w/w, tolnaftate1 % w/w, iodochlorhydroxyquinoline 1 %w/w, chlorocresol 0.1 % w/w. CRM / 15g (Ind-Swift Limited) | $ 0.59 |
Quadrimix Betamethasone dipropionate0.05 % w/w, gentamicinsulphate 0.1 % w/w, tolnaftate1 % w/w, iodochlorhydroxyquinoline 1 %w/w, chlorocresol 0.1 % w/w. CRM / 5g (Ind-Swift Limited) | $ 0.28 |
Scanderma Plus (Indonesia) | |
Scanderma Plus 10 g x 1's (Tempo scan pacific) | $ 2.29 |
Skizon (Indonesia) | |
Temprosone (Vietnam) | |
Temprosone 0.05 % x 1 tube 30 g | |
See 77 substitutes for Betamethasone - Behvazan 001% |
References
- DailyMed. "BETAMETHASONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubChem. "betamethasone". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "betamethasone". http://www.drugbank.ca/drugs/DB00443 (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Betamethasone - Behvazan 001% are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Betamethasone - Behvazan 001%. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology